О клинике
Назад
О клинике О нас Хадасса в цифрах История Фототур Схема территории Новости События
Отделения
Назад
Аллергология и иммунология Гастроэнтерология Гематология Генетика Гинекология Дерматология Инфекционные заболевания Кардиология Неврология Нейрохирургия Нефрология Онкология Ортопедия Отоларингология Офтальмология Педиатрия Пластическая хирургия Психиатрия Пульмонология Радиология Радиотерапия Реабилитология Сосудистая хирургия Стоматология Торакальная хирургия Урология Хирургия Челюстно-лицевая хирургия Эндокринология Ядерная медицина Редкие заболевания Трансплантация костного мозга
Врачи
Пациентам
Назад
Отзывы и истории успеха Медицинские брошюры Пошаговое руководство Болезни от А до Я Процедуры и услуги от А до Я Прейскурант лекарств
Специалистам
Назад
Стажировки
Контакты
info@hds.org.il +9722 560-9534
О клинике
Назад
О клинике О нас Хадасса в цифрах История Фототур Схема территории Новости События
Отделения
Назад
Аллергология и иммунология Гастроэнтерология Гематология Генетика Гинекология Дерматология Инфекционные заболевания Кардиология Неврология Нейрохирургия Нефрология Онкология Ортопедия Отоларингология Офтальмология Педиатрия Пластическая хирургия Психиатрия Пульмонология Радиология Радиотерапия Реабилитология Сосудистая хирургия Стоматология Торакальная хирургия Урология Хирургия Челюстно-лицевая хирургия Эндокринология Ядерная медицина Редкие заболевания Трансплантация костного мозга
Врачи
Пациентам
Назад
Отзывы и истории успеха Медицинские брошюры Пошаговое руководство Болезни от А до Я Процедуры и услуги от А до Я Прейскурант лекарств
Специалистам
Назад
Стажировки
Контакты
info@hds.org.il +9722 560-9534

Симона Гласберг

Отделение: Эндокринология, Онкология
Должность: Эндокринолог
Языки: Английский
Принимает: только взрослых
Написать в WhatsApp Записаться на прием

Доктор Симона Гласберг - руководитель центра лечения нейроэндокринных опухолей.

Образование

Выпускница медицинского факультета Ясского университета (Румыния) (1994 г.)

Специализация

  • Карциноидные опухоли легкого, органов ЖКТ
  • Нейроэндокринные опухоли поджелудочной железы
  • Медуллярная карцинома щитовидной железы
  • Феохромоцитома и параганглиома
  • Множественные эндокринные неоплазии (МЕН1, МЕН2, VHL)
  • Карцинома надпочечника
  • Опухоли гипофиза

Профессиональная деятельность

Руководитель центра лечения нейроэндокринных опухолей.

Научные публикации

Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implications
PRRT in high-grade digestive neuroendocrine neoplasms (NET G3 and NEC)
Use and perceived utility of [18 F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022
Clinical characteristics of a large familial cohort with Medullary thyroid cancer and germline Cys618Arg RET mutation in an Israeli multicenter study
In Response
Impact of Single-Time-Point Estimates of 177Lu-PRRT Absorbed Doses on Patient Management: Validation of a Trained Multiple-Linear-Regression Model in 159 Patients and 477 Therapy Cycles
Emerging therapies for advanced insulinomas and glucagonomas
Pancreatic metastases in patients with neuroendocrine neoplasms: A multi-centre cohort study
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study
Clinical and pathologic characteristics of appendiceal neuroendocrine neoplasms diagnosed during pregnancy
A Comparison of Outcomes in Medullary Thyroid Carcinoma Patients With and Without a Preoperative Diagnosis: A Multicenter Retrospective Cohort Study
Outcome of COVID-19 infections in patients with adrenal insufficiency and excess
Deliberate Compensated Vasoplegia-A Novel Pharmaceutical Approach for Controlling Blood Pressure During Surgery for Pheochromocytoma
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study
Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report
Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center's 20 years of Experience
miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L2
European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease
Practical lessons from treating medullary thyroid carcinoma patients harboring a RET-alteration: Pralsetinib-induced acute confusional state
ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors
Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)
Liquid biopsy reveals collateral tissue damage in cancer
The Autophagy Inhibitor Chloroquine, Alone or in Combination with mTOR Inhibitors, Displays Anti-Tumor Effects in In Vitro and In Vivo Lung Carcinoid Models
Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients
Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)
Corrigendum to 'Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study' [European Journal of Cancer 154 (2021) 246-252]
Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study
Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMORS - IMPROVEMENTS IN THE PROTOCOL FOR MEASUREMENT OF PATIENT RADIATION EXPOSURE
Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
An Update on the Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH)
Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in 68Ga-DOTATATE PET/CT studies?
VHL-Related Neuroendocrine Neoplasms And Beyond: An Israeli Specialized Center Real-Life Report
Update in carcinoid heart disease - the heart of the matter
Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era
Distinctive features of pancreatic neuroendocrine neoplasms exhibiting an increment in proliferative activity during the course of the disease
Multiple Endocrine Neoplasia Type 1 (MEN1) 5'UTR Deletion, in MEN1 Family, Decreases Menin Expression
Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs)
The effect of prophylactic surgery in survival and HRQoL in appendiceal NEN
Health-related quality of life in neuroendocrine neoplasia: a critical review
The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study
Severe Symptomatic Hypernatremia in a Patient with Panhypopituitarism after Short-Term Discontinuation of Desmopressin
Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia
Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma
Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management
PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Authors' Response to the Letter by Lamarca et al. Entitled "Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy
Carcinoid Syndrome: Updates and Review of Current Therapy
Diagnostic and Management Challenges in Vasoactive Intestinal Peptide Secreting Tumors: A Series of 15 Patients
Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms
Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine Tumors
Clinico-pathologic and dynamic prognostic factors in sporadic and familial medullary thyroid carcinoma: an Israeli multi-center study
Intractable Hypokalemia: a Red Herring for Rapidly Evolving Ectopic Cushing's Syndrome
The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
Predictive power of the post-treatment scans after the initial or first two courses of [177Lu]-DOTA-TATE
Bilateral Medullary Thyroid Carcinoma in a 3-Year-Old Female Patient with Multiple Endocrine Neoplasia 2A Syndrome Undergoing Prophylactic Thyroidectomy: Should Current Guidelines Be Revised?
Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
Unmet Needs in Appendiceal Neuroendocrine Neoplasms
Gastric Carcinoids
Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)
Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors
Combining chloroquine with RAD001 inhibits tumor growth in a NEN mouse model
Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study
Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice
Update in the Therapy of Advanced Neuroendocrine Tumors
Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors
Non-functioning pancreatic neuroendocrine tumors: Surgery or observation?
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical Markers
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms. Systemic Therapy 2: Chemotherapy
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents
Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours
ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification
The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature
Valve Replacement in Patients with Carcinoid Heart Disease: Choosing the Right Valve at the Right Time
Vandetanib induces a marked anti-tumor effect and amelioration of ectopic Cushing's syndrome in a medullary thyroid carcinoma patient
Abrogation of Autophagy by Chloroquine Alone or in Combination with mTOR Inhibitors Induces Apoptosis in Neuroendocrine Tumor Cells
Appendiceal neuroendocrine neoplasms: diagnosis and management
Pancreatic neuroendocrine tumors with transformation to insulinoma: an unusual presentation of a rare disease
Carcinoid Heart Disease: From Pathophysiology to Treatment--'Something in the Way It Moves'
Clinical features of pancreatic neuroendocrine tumors
Laparoscopic resection of pancreatic neuroendocrine tumors
Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis
Metastatic type 1 gastric carcinoid: a real threat or just a myth?
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
Laparoscopic resection of primary midgut carcinoid tumors
Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study
Current size criteria for the management of neuroendocrine tumors of the appendix: are they valid? Clinical experience and review of the literature
New drugs in the therapy of neuroendocrine tumors
Inhibition of mTOR in carcinoid tumors
The role of cell lines in the study of neuroendocrine tumors
Fulminant ectopic Cushing syndrome in a patient with metastatic neuroendocrine carcinoma and Crohn's disease
Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma
Total versus hemithyroidectomy for microscopic papillary thyroid cancer
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity
Prognostic value of post-thyroidectomy thyroglobulin levels in patients with differentiated thyroid cancer
Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas
Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study
Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression
The potential role of mTOR inhibitors in the treatment of endocrine tumors
Clinically silent chromaffin-cell tumors: Tumor characteristics and long-term prognosis in patients with incidentally discovered pheochromocytomas
Metastatic bronchial neuroendocrine tumor to the pineal gland: a unique manifestation of a rare disease
The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells
Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors
Well-differentiated thyroid carcinoma: comparison of microscopic and macroscopic disease
Unusual clinical presentations of giant prolactinomas
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms
The role of somatostatin analogues in the treatment of neuroendocrine tumours
Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line
Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005
Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials
Показать ещё 117 статей Скрыть статьи
Заболевания
Болезнь фон Гиппеля-Линдау
Карциноидные опухоли желудка
Нейроэндокринные опухоли
Первичный гиперпаратиреоз
Эстезионейробластома
Показать ещё
Инсулинома
Карциноидные опухоли
Карциноидные опухоли легких
Процедуры
Таргетная терапия
Пептид-рецепторная радионуклидная терапия
Терапия радиоактивным йодом

Новости

Новости «Хадассы» Интервью с д-ром Симоной Гласберг
Мировые новости медицины Центр лечения нейроэндокринных опухолей клиники "Хадасса" получил европейское признание
Мировые новости медицины Новое слово в лечении нейроэндокринных опухолей
Мировые новости медицины Препарат Эверолимус в лечении НЭО
Новости «Хадассы» 22/12/2011 Лечение нейроэндокринных опухолей.
Смотреть все новости
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы